New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


WPC Travel Grant

Global update

World Parkinson’s Congress 2016: travel grant applications now open

Financial support available for attendees travelling to WPC 2016

READ MORE

In my country

Parkinson’s in South Africa

An in-depth look at how Parkinson's is managed in South Africa

READ MORE
Timo's travel tips

Perspectives

10 top tips for travelling with Parkinson’s

Finnish author and campaigner Timo Montonen shares his top tips

READ MORE